Literature DB >> 1588505

Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse.

F G King1, R L Dedrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1588505     DOI： 10.1007/bf01143187

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  8 in total

1.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

Review 2.  Cisplatin pharmacokinetics: applications of a physiological model.

Authors:  F F Farris; R L Dedrick; F G King
Journal:  Toxicol Lett       Date:  1988-10       Impact factor: 4.372

3.  Pharmacokinetic model for 2-amino-1,3,4-thiadiazole in mouse, dog, and monkey.

Authors:  F G King; R L Dedrick
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

4.  Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

Authors:  F F Farris; F G King; R L Dedrick; C L Litterst
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

5.  Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.

Authors:  F G King; R L Dedrick; F F Farris
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

6.  Comparative distribution and excretion of carboplatin and cisplatin in mice.

Authors:  Z H Siddik; M Jones; F E Boxall; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.

Authors:  Z H Siddik; D R Newell; F E Boxall; K R Harrap
Journal:  Biochem Pharmacol       Date:  1987-06-15       Impact factor: 5.858

8.  Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species.

Authors:  F G King; R L Dedrick; J M Collins; H B Matthews; L S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  1983-03-15       Impact factor: 4.219
  8 in total
  4 in total

Review 1.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

2.  Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.

Authors:  Liqiong Cai; Gaofei Xu; Changying Shi; Dandan Guo; Xu Wang; Juntao Luo
Journal:  Biomaterials       Date:  2014-10-31       Impact factor: 12.479

3.  Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system.

Authors:  N Nishiyama; Y Kato; Y Sugiyama; K Kataoka
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

4.  Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice.

Authors:  Hardeep S Oberoi; Natalia V Nukolova; Frederic C Laquer; Larisa Y Poluektova; Jiangeng Huang; Yazen Alnouti; Masanao Yokohira; Lora L Arnold; Alexander V Kabanov; Samuel M Cohen; Tatiana K Bronich
Journal:  Int J Nanomedicine       Date:  2012-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.